Research Article

Prediction of Methotrexate Clinical Response in Portuguese Rheumatoid Arthritis Patients: Implication of MTHFR rs1801133 and ATIC rs4673993 Polymorphisms

Figure 1

Methotrexate action mechanism. Left panel represents the intervention of MTX in de novo pyrimidine synthesis, folate, and methionine pathways by the inhibition of key enzymes. Right panel shows the effect of MTX in de novo purine synthesis and adenosine pathway by ATIC inhibition. 5-MTHF: 5-methyltetrahydrofolate; 5,10-MTHF: 5,10-methylenetetrahydrofolate; ABC: ATP-binding cassette; ADORA: adenosine receptor; AICAR: 5-aminoimidazole-4-carboxamide ribonucleotide; AMP: adenosine monophosphate; ATIC: 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase; ATP: adenosine triphosphate; DHF: dihydrofolate; dTMP: deoxythymidine monophosphate; dUMP: deoxyuridine monophosphate; FAICAR: 5-formamidoimidazole-4-carboxamide ribonucleotide; IMP: inosine monophosphate; MTHFR: methylenetetrahydrofolate reductase; MTX: methotrexate; MTXPG: methotrexate polyglutamate; SLC: solute carrier; THF: tetrahydrofolate.
368681.fig.001